葛兰素史克GSK-201401-32ndAnnuaJPMorganHeathcareConference_By_CFO

32ndAnnualJPMorganHealthcareConferenceSimonDingemans,CFOJanuary14,2014DelivermoreproductsofvalueGrowadiversifiedglobalbusinessSimplifytheoperatingmodel?Multipledriversofsalesgrowthinplace?Significantpipelinefilings&approvals?Continuedrestructuringofoperatingcosts?Furtherfinancialefficiencygains?Strongcashgenerationandreturnstoshareholders2013:Ayearofstrategicdelivery14January201432ndAnnualJPMorganHealthcareConference20%9mYTDsales+5%*Salesgrowth9mYTD13%9mYTDsales-2%*Salesgrowthfor9mYTD+3%*(exCervarixinJapan)Furtherstrengtheningofbusinessmix3Salesgrowth(exdisposals)9monthsYTD:+2%*(CER)14January201432ndAnnualJPMorganHealthcareConference67%9mYTDsales+1%*Salesgrowth9mYTD*CERgrowthratesexcludingdisposals(Vesicare,OTCdivestments,AustralianClass